Literature DB >> 27624814

Hereditary breast and ovarian cancer: successful systematic implementation of a group approach to genetic counselling.

Patrick R Benusiglio1, Marina Di Maria2, Leila Dorling3, Anne Jouinot2,4, Antoine Poli2, Sophie Villebasse2, Marine Le Mentec2, Béatrice Claret5, Diane Boinon5, Olivier Caron2.   

Abstract

The increase in referrals to cancer genetics clinics, partially associated with the "Angelina Jolie effect", presents a challenge to existing services, many are already running at full capacity. More efficient ways to deliver genetic counselling are therefore urgently needed. We now systematically offer group instead of standard individual counselling to patients with suspected Hereditary Breast and Ovarian Cancer. Group sessions last 30 min. The first twenty consist of a presentation by the genetic counsellor, the next ten of a discussion involving a cancer geneticist and a psychologist. A short individual consultation ensues, where personal and family issues are addressed and consent obtained. Blood is drawn afterwards. Satisfaction and knowledge are evaluated. We report data for the Oct-2014-Aug-2015 period. 210 patients attended group counselling, up to eight simultaneously. We always fitted them within a 4-h time frame. Mean satisfaction score was 41/43. Knowledge scores increased from 3.1/6 to 4.9/6 post-counselling (p value < 2.2 × 10-16). Thanks to group counselling, we have withstood increases in referrals without compromising care. The "Angelina Jolie effect" and rapid developments in personalized medicine threaten to overwhelm cancer genetics clinics. In this context, our innovative approach should ensure that all patients have access to approved services.

Entities:  

Keywords:  BRCA1; BRCA2; Delivery of health care; Genetic counselling; Hereditary breast and ovarian cancer syndrome; Patient education

Mesh:

Year:  2017        PMID: 27624814     DOI: 10.1007/s10689-016-9929-x

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  12 in total

Review 1.  American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility.

Authors:  Mark E Robson; Courtney D Storm; Jeffrey Weitzel; Dana S Wollins; Kenneth Offit
Journal:  J Clin Oncol       Date:  2010-01-11       Impact factor: 44.544

2.  Cancer Core Europe: a consortium to address the cancer care-cancer research continuum challenge.

Authors:  Alexander M M Eggermont; Carlos Caldas; Ulrik Ringborg; René Medema; Josep Tabernero; Otmar Wiestler
Journal:  Eur J Cancer       Date:  2014-09-25       Impact factor: 9.162

3.  Patient outcomes associated with group and individual genetic counseling formats.

Authors:  Erin Rothwell; Wendy Kohlmann; Kory Jasperson; Amanda Gammon; Bob Wong; Anita Kinney
Journal:  Fam Cancer       Date:  2012-03       Impact factor: 2.375

Review 4.  Olaparib: first global approval.

Authors:  Emma D Deeks
Journal:  Drugs       Date:  2015-02       Impact factor: 9.546

5.  Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials.

Authors:  Funda Meric-Bernstam; Lauren Brusco; Kenna Shaw; Chacha Horombe; Scott Kopetz; Michael A Davies; Mark Routbort; Sarina A Piha-Paul; Filip Janku; Naoto Ueno; David Hong; John De Groot; Vinod Ravi; Yisheng Li; Raja Luthra; Keyur Patel; Russell Broaddus; John Mendelsohn; Gordon B Mills
Journal:  J Clin Oncol       Date:  2015-05-26       Impact factor: 44.544

6.  Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial.

Authors:  Amit M Oza; David Cibula; Ana Oaknin Benzaquen; Christopher Poole; Ron H J Mathijssen; Gabe S Sonke; Nicoletta Colombo; Jiří Špaček; Peter Vuylsteke; Holger Hirte; Sven Mahner; Marie Plante; Barbara Schmalfeldt; Helen Mackay; Jacqui Rowbottom; Elizabeth S Lowe; Brian Dougherty; J Carl Barrett; Michael Friedlander
Journal:  Lancet Oncol       Date:  2014-12-04       Impact factor: 41.316

7.  Development, testing, and validation of a patient satisfaction questionnaire for use in the clinical genetics setting.

Authors:  Barbara Zellerino; Sharon A Milligan; Ron Brooks; Debra L Freedenberg; Dave S Collingridge; Marc S Williams
Journal:  Am J Med Genet C Semin Med Genet       Date:  2009-08-15       Impact factor: 3.908

8.  American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.

Authors:  Mark E Robson; Angela R Bradbury; Banu Arun; Susan M Domchek; James M Ford; Heather L Hampel; Stephen M Lipkin; Sapna Syngal; Dana S Wollins; Noralane M Lindor
Journal:  J Clin Oncol       Date:  2015-08-31       Impact factor: 44.544

9.  The time-consuming demands of the practice of medical genetics in the era of advanced genomic testing.

Authors:  Rivka Sukenik-Halevy; Mark David Ludman; Shay Ben-Shachar; Annick Raas-Rothschild
Journal:  Genet Med       Date:  2015-07-16       Impact factor: 8.822

10.  The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services.

Authors:  D Gareth Evans; Julian Barwell; Diana M Eccles; Amanda Collins; Louise Izatt; Chris Jacobs; Alan Donaldson; Angela F Brady; Andrew Cuthbert; Rachel Harrison; Sue Thomas; Anthony Howell; Zosia Miedzybrodzka; Alex Murray
Journal:  Breast Cancer Res       Date:  2014-09-19       Impact factor: 6.466

View more
  7 in total

1.  Operationalizing the Reciprocal Engagement Model of Genetic Counseling Practice: a Framework for the Scalable Delivery of Genomic Counseling and Testing.

Authors:  Tara Schmidlen; Amy C Sturm; Shelly Hovick; Laura Scheinfeldt; J Scott Roberts; Lindsey Morr; Joseph McElroy; Amanda E Toland; Michael Christman; Julianne M O'Daniel; Erynn S Gordon; Barbara A Bernhardt; Kelly E Ormond; Kevin Sweet
Journal:  J Genet Couns       Date:  2018-02-19       Impact factor: 2.537

Review 2.  The composition and capacity of the clinical genetics workforce in high-income countries: a scoping review.

Authors:  Nick Dragojlovic; Kennedy Borle; Nicola Kopac; Ursula Ellis; Patricia Birch; Shelin Adam; Jan M Friedman; Amy Nisselle; Alison M Elliott; Larry D Lynd
Journal:  Genet Med       Date:  2020-06-24       Impact factor: 8.822

Review 3.  Next-Generation Service Delivery: A Scoping Review of Patient Outcomes Associated with Alternative Models of Genetic Counseling and Genetic Testing for Hereditary Cancer.

Authors:  Jeanna M McCuaig; Susan Randall Armel; Melanie Care; Alexandra Volenik; Raymond H Kim; Kelly A Metcalfe
Journal:  Cancers (Basel)       Date:  2018-11-13       Impact factor: 6.639

Review 4.  Communication about genetic testing with breast and ovarian cancer patients: a scoping review.

Authors:  Chris Jacobs; Christine Patch; Susan Michie
Journal:  Eur J Hum Genet       Date:  2018-12-20       Impact factor: 4.246

5.  Understanding the Information Needs of Patients With Ovarian Cancer Regarding Genetic Testing to Inform Intervention Design: Interview Study.

Authors:  Yan Zhang; Siqi Yi; Ciaran B Trace; Marian Yvette Williams-Brown
Journal:  JMIR Cancer       Date:  2022-02-08

6.  Provider's Perceptions of Barriers and Facilitators for Latinas to Participate in Genetic Cancer Risk Assessment for Hereditary Breast and Ovarian Cancer.

Authors:  Alejandra Hurtado-de-Mendoza; Kristi Graves; Sara Gómez-Trillos; Lyndsay Anderson; Claudia Campos; Chalanda Evans; Selma Stearns; Qi Zhu; Nathaly Gonzalez; Vanessa B Sheppard
Journal:  Healthcare (Basel)       Date:  2018-09-17

7.  Group plus "mini" individual pre-test genetic counselling sessions for hereditary cancer shorten provider time and improve patient satisfaction.

Authors:  Jaclyn Hynes; Andrée MacMillan; Sara Fernandez; Karen Jacob; Shannon Carter; Sarah Predham; Holly Etchegary; Lesa Dawson
Journal:  Hered Cancer Clin Pract       Date:  2020-02-19       Impact factor: 2.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.